Operating Lease, Right-of-Use Asset of INTEGRATED BIOPHARMA INC from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
INTEGRATED BIOPHARMA INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • INTEGRATED BIOPHARMA INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $612,000, a 61% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

INTEGRATED BIOPHARMA INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $612,000 -$946,000 -61% 30 Sep 2025 10-Q 10 Nov 2025 2026 Q1
Q2 2025 $855,000 -$935,000 -52% 30 Jun 2025 10-Q 10 Nov 2025 2026 Q1
Q1 2025 $1,095,000 -$925,000 -46% 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 $1,323,000 -$924,000 -41% 31 Dec 2024 10-Q 13 Feb 2025 2025 Q2
Q3 2024 $1,558,000 -$914,000 -37% 30 Sep 2024 10-Q 13 Nov 2024 2025 Q1
Q2 2024 $1,790,000 -$833,000 -32% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q1 2024 $2,020,000 -$819,000 -29% 31 Mar 2024 10-Q 10 May 2024 2024 Q3
Q4 2023 $2,247,000 -$806,000 -26% 31 Dec 2023 10-Q 12 Feb 2024 2024 Q2
Q3 2023 $2,472,000 -$174,000 -6.6% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q1
Q2 2023 $2,623,000 +$756,000 +40% 30 Jun 2023 10-K 20 Sep 2024 2024 FY
Q1 2023 $2,839,000 +$848,000 +43% 31 Mar 2023 10-Q 11 May 2023 2023 Q3
Q4 2022 $3,053,000 +$938,000 +44% 31 Dec 2022 10-Q 10 Feb 2023 2023 Q2
Q3 2022 $2,646,000 +$407,000 +18% 30 Sep 2022 10-Q 10 Nov 2022 2023 Q1
Q2 2022 $1,867,000 -$498,000 -21% 30 Jun 2022 10-K 15 Sep 2023 2023 FY
Q1 2022 $1,991,000 -$469,000 -19% 31 Mar 2022 10-Q 12 May 2022 2022 Q3
Q4 2021 $2,115,000 -$468,000 -18% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q2
Q3 2021 $2,239,000 -$465,000 -17% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q1
Q2 2021 $2,365,000 -$459,000 -16% 30 Jun 2021 10-K 13 Sep 2022 2022 FY
Q1 2021 $2,460,000 -$483,000 -16% 31 Mar 2021 10-Q 13 May 2021 2021 Q3
Q4 2020 $2,583,000 -$469,000 -15% 31 Dec 2020 10-Q 12 Feb 2021 2021 Q2
Q3 2020 $2,704,000 -$465,000 -15% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q1
Q2 2020 $2,824,000 -$460,000 -14% 30 Jun 2020 10-K 02 Sep 2021 2021 FY
Q1 2020 $2,943,000 -$456,000 -13% 31 Mar 2020 10-Q 13 May 2020 2020 Q3
Q4 2019 $3,052,000 -$461,000 -13% 31 Dec 2019 10-Q 12 Feb 2020 2020 Q2
Q3 2019 $3,169,000 -$457,000 -13% 30 Sep 2019 10-Q 13 Nov 2019 2020 Q1
Q2 2019 $3,284,000 30 Jun 2019 10-K 23 Sep 2020 2020 FY
Q1 2019 $3,399,000 31 Mar 2019 10-Q 15 May 2019 2019 Q3
Q4 2018 $3,513,000 31 Dec 2018 10-Q 13 Feb 2019 2019 Q2
Q3 2018 $3,626,000 30 Sep 2018 10-Q 09 Nov 2018 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.